Section Arrow
JAGX.NASDAQ
- Jaguar Health
(Financial Status)
Quotes are at least 15-min delayed:2024/05/01 22:05 EDT
Last
 0.2276
+0.0129 (+6.01%)
Day High 
0.2336 
Prev. Close
0.2147 
1-M High
0.2598 
Volume 
35.94M 
Bid
0.2167
Ask
0.217
Day Low
0.201 
Open
0.2271 
1-M Low
0.071 
Market Cap 
61.67M 
Currency USD 
P/E -- 
%Yield
10-SMA 0.18 
20-SMA 0.14 
50-SMA 0.1 
52-W High 1.22 
52-W Low 0.0512 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.79/-0.04
Enterprise Value
93.55M
Balance Sheet
Book Value Per Share
0.02
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
9.76M
Operating Revenue Per Share
0.04
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
CTMXCytomX Therapeutics5.13+3.5+214.72%-- 
DNAGinkgo Bioworks Holdings0.8421-0.049-5.50%-- 
JAGXJaguar Health0.2276+0.0129+6.01%-- 
TGTXTG Therapeutics15.85+2.19+16.03%151.78PE
CYCCCyclacel Pharmaceuticals2.6802+0.5602+26.42%-- 
Quotes are at least 15-min delayed:2024/05/01 22:05 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.